qualityassurance
★    

2026-01-16 13:52
(160 d 04:41 ago)

Posting: # 24547
Views: 866
 

 Repeat BE only for failed analyte [Study As­sess­ment]

Post reply
Hello Experts,

We have conducted BE of modified release fixed dose combination product. BE is successful for analyte-A while failing in AUCinf on a border line due to one outlier subject for analyte-B. Since our study is successful for analyte-A, is it possible that in new study (without change in formulation) we only analyse analyte-B and prove BE for analyte-b only. Will it be acceptable to regulatory authority such as EMA?

Any one has applied this approach in past and was it accepted by regulatory authorities?

Regards,
QA
 
UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
160 visitors (0 registered, 160 guests [including 26 identified bots]).
Forum time: 19:33 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5